January 31st, 2014

Abbott Can't Escape FCA Suit Over Drug Marketing, Kickbacks

By Kelly Knaub
Law360

A Pennsylvania federal judge refused Thursday to dismiss a former Abbott Laboratories employee’s suit claiming the company submitted false claims to government health programs by pushing its cholesterol drug TriCor for off-label uses and paying kickbacks to physicians.

In a 50-page memorandum, U.S. District Judge C. Darnell Jones II said that relator Amy Bergman “provides myriad details of Abbott’s marketing statements that contradict its FDA-approved label,” rejecting Abbott’s argument that the allegations of its False Claims Act violations are not specific enough to proceed.

Read more: http://www.law360.com/competition/articles/505985/abbott-can-t-escape-fca-suit-over-drug-marketing-kickbacks

Comments

Add your own Comment

(optional)